| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Islets of Langerhans | 39 | 2024 | 549 | 8.910 |
Why?
|
| Insulin-Secreting Cells | 35 | 2023 | 408 | 7.060 |
Why?
|
| Pancreas | 19 | 2024 | 253 | 3.770 |
Why?
|
| Pancreas, Exocrine | 5 | 2024 | 18 | 2.740 |
Why?
|
| Insulin | 30 | 2023 | 1148 | 2.310 |
Why?
|
| Glucagon-Secreting Cells | 10 | 2019 | 25 | 2.150 |
Why?
|
| Microcirculation | 4 | 2021 | 105 | 2.130 |
Why?
|
| Diabetes Mellitus | 9 | 2024 | 744 | 1.640 |
Why?
|
| Diabetes Mellitus, Type 2 | 15 | 2020 | 1181 | 1.360 |
Why?
|
| Mice | 50 | 2024 | 11858 | 1.230 |
Why?
|
| Animals | 65 | 2024 | 27536 | 1.070 |
Why?
|
| Somatostatin-Secreting Cells | 4 | 2019 | 7 | 1.010 |
Why?
|
| Diabetes Mellitus, Experimental | 9 | 2015 | 191 | 0.980 |
Why?
|
| Immunohistochemistry | 8 | 2019 | 1801 | 0.890 |
Why?
|
| Pancreatic Polypeptide-Secreting Cells | 2 | 2013 | 5 | 0.870 |
Why?
|
| Green Fluorescent Proteins | 12 | 2014 | 309 | 0.850 |
Why?
|
| Mice, Transgenic | 22 | 2021 | 1579 | 0.840 |
Why?
|
| Diabetes Mellitus, Type 1 | 5 | 2016 | 565 | 0.840 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2019 | 603 | 0.800 |
Why?
|
| Cell Count | 4 | 2017 | 199 | 0.780 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2013 | 1255 | 0.740 |
Why?
|
| Promoter Regions, Genetic | 7 | 2014 | 961 | 0.710 |
Why?
|
| Glucagon | 9 | 2023 | 111 | 0.690 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2017 | 121 | 0.670 |
Why?
|
| Absorptiometry, Photon | 1 | 2019 | 102 | 0.610 |
Why?
|
| Microscopy, Confocal | 6 | 2019 | 280 | 0.610 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 1983 | 0.610 |
Why?
|
| Biological Variation, Individual | 1 | 2017 | 7 | 0.600 |
Why?
|
| Sulfonylurea Compounds | 2 | 2017 | 66 | 0.580 |
Why?
|
| Models, Biological | 7 | 2021 | 1766 | 0.560 |
Why?
|
| Humans | 55 | 2024 | 90014 | 0.540 |
Why?
|
| Body Mass Index | 2 | 2019 | 776 | 0.530 |
Why?
|
| Cell Differentiation | 6 | 2015 | 1533 | 0.500 |
Why?
|
| Embryonic Stem Cells | 3 | 2011 | 81 | 0.480 |
Why?
|
| Metabolome | 1 | 2015 | 51 | 0.470 |
Why?
|
| Hypertriglyceridemia | 1 | 2015 | 68 | 0.470 |
Why?
|
| Regeneration | 3 | 2016 | 151 | 0.450 |
Why?
|
| Glucose Intolerance | 4 | 2017 | 94 | 0.450 |
Why?
|
| Glucose | 7 | 2018 | 629 | 0.450 |
Why?
|
| Obesity | 3 | 2019 | 972 | 0.450 |
Why?
|
| Female | 34 | 2021 | 46617 | 0.440 |
Why?
|
| Organ Size | 5 | 2017 | 372 | 0.440 |
Why?
|
| Blood Glucose | 9 | 2021 | 837 | 0.430 |
Why?
|
| Islets of Langerhans Transplantation | 5 | 2014 | 242 | 0.420 |
Why?
|
| Pancreatic Diseases | 2 | 2023 | 53 | 0.410 |
Why?
|
| Microscopy, Fluorescence | 6 | 2012 | 434 | 0.410 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2002 | 122 | 0.410 |
Why?
|
| Insulin Resistance | 6 | 2019 | 353 | 0.400 |
Why?
|
| Ferrets | 3 | 2023 | 48 | 0.400 |
Why?
|
| Swine | 4 | 2023 | 590 | 0.400 |
Why?
|
| Oxidative Stress | 1 | 2015 | 458 | 0.390 |
Why?
|
| Male | 25 | 2021 | 42705 | 0.370 |
Why?
|
| Gene Expression | 7 | 2015 | 1309 | 0.360 |
Why?
|
| Proprotein Convertase 1 | 1 | 2010 | 11 | 0.350 |
Why?
|
| Transcription Factors | 5 | 2011 | 1665 | 0.350 |
Why?
|
| Luminescent Measurements | 1 | 2010 | 64 | 0.350 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2010 | 47 | 0.350 |
Why?
|
| Homeodomain Proteins | 6 | 2015 | 559 | 0.340 |
Why?
|
| Cell Proliferation | 3 | 2015 | 1670 | 0.330 |
Why?
|
| Molecular Imaging | 1 | 2010 | 66 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 11 | 2020 | 3253 | 0.330 |
Why?
|
| Inflammation | 1 | 2015 | 981 | 0.320 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2009 | 80 | 0.310 |
Why?
|
| Capillaries | 2 | 2020 | 90 | 0.310 |
Why?
|
| Hyperglycemia | 3 | 2021 | 172 | 0.310 |
Why?
|
| Endocrine Disruptors | 2 | 2019 | 27 | 0.300 |
Why?
|
| Teratoma | 1 | 2008 | 52 | 0.300 |
Why?
|
| Liver | 4 | 2007 | 1211 | 0.300 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2007 | 5 | 0.300 |
Why?
|
| Adult | 17 | 2019 | 26836 | 0.300 |
Why?
|
| Transgenes | 2 | 2007 | 185 | 0.300 |
Why?
|
| Rabbits | 3 | 2023 | 640 | 0.290 |
Why?
|
| Mutation | 4 | 2017 | 4169 | 0.290 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2014 | 663 | 0.280 |
Why?
|
| Calcium | 6 | 2009 | 1179 | 0.280 |
Why?
|
| Models, Theoretical | 4 | 2018 | 493 | 0.280 |
Why?
|
| Trans-Activators | 4 | 2015 | 443 | 0.270 |
Why?
|
| Luminescent Proteins | 2 | 2005 | 144 | 0.260 |
Why?
|
| Polycystic Ovary Syndrome | 3 | 2004 | 207 | 0.260 |
Why?
|
| Mice, Obese | 3 | 2010 | 44 | 0.260 |
Why?
|
| Infarction | 1 | 2005 | 27 | 0.250 |
Why?
|
| Polyethylene Glycols | 2 | 2020 | 360 | 0.240 |
Why?
|
| Young Adult | 5 | 2019 | 6418 | 0.240 |
Why?
|
| Polymorphism, Genetic | 4 | 2004 | 824 | 0.240 |
Why?
|
| Somatostatin | 2 | 2018 | 53 | 0.240 |
Why?
|
| Pregnancy | 8 | 2019 | 3046 | 0.240 |
Why?
|
| Animals, Newborn | 4 | 2011 | 524 | 0.230 |
Why?
|
| RNA, Messenger | 6 | 2015 | 2026 | 0.230 |
Why?
|
| Acinar Cells | 1 | 2024 | 7 | 0.230 |
Why?
|
| Adenosine Triphosphate | 4 | 2006 | 316 | 0.230 |
Why?
|
| Aging | 4 | 2018 | 727 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 4 | 2021 | 511 | 0.230 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2004 | 96 | 0.220 |
Why?
|
| Glucose Tolerance Test | 5 | 2016 | 227 | 0.220 |
Why?
|
| Endocrine System | 1 | 2023 | 17 | 0.220 |
Why?
|
| Mice, Inbred NOD | 3 | 2015 | 198 | 0.220 |
Why?
|
| Biosensing Techniques | 1 | 2004 | 73 | 0.220 |
Why?
|
| Flow Cytometry | 3 | 2014 | 690 | 0.220 |
Why?
|
| Apoptosis | 4 | 2008 | 1718 | 0.210 |
Why?
|
| In Vitro Techniques | 4 | 2021 | 996 | 0.210 |
Why?
|
| Regional Blood Flow | 1 | 2023 | 198 | 0.210 |
Why?
|
| Endoplasmic Reticulum | 1 | 2004 | 255 | 0.200 |
Why?
|
| Infant | 4 | 2017 | 3189 | 0.200 |
Why?
|
| Case-Control Studies | 3 | 2017 | 1868 | 0.200 |
Why?
|
| Biological Evolution | 1 | 2010 | 974 | 0.200 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 380 | 0.200 |
Why?
|
| Mammals | 1 | 2024 | 237 | 0.200 |
Why?
|
| Image Enhancement | 1 | 2005 | 565 | 0.200 |
Why?
|
| Embryo, Mammalian | 3 | 2017 | 223 | 0.190 |
Why?
|
| Cytological Techniques | 1 | 2021 | 30 | 0.190 |
Why?
|
| Calcium Signaling | 2 | 2021 | 138 | 0.180 |
Why?
|
| Dynamins | 1 | 2021 | 50 | 0.180 |
Why?
|
| Methylmethacrylates | 1 | 2020 | 8 | 0.170 |
Why?
|
| Paper | 1 | 2020 | 12 | 0.170 |
Why?
|
| Kidney | 1 | 2005 | 1148 | 0.170 |
Why?
|
| Methacrylates | 1 | 2020 | 9 | 0.170 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 476 | 0.170 |
Why?
|
| Up-Regulation | 4 | 2018 | 726 | 0.170 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2014 | 312 | 0.170 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2020 | 85 | 0.170 |
Why?
|
| Paracrine Communication | 1 | 2019 | 32 | 0.170 |
Why?
|
| Prediabetic State | 2 | 2010 | 36 | 0.170 |
Why?
|
| Toluidines | 1 | 2019 | 18 | 0.170 |
Why?
|
| Genetic Variation | 3 | 2001 | 1380 | 0.170 |
Why?
|
| Endocrine Cells | 1 | 2019 | 3 | 0.160 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 45 | 0.160 |
Why?
|
| Cellulose | 1 | 2020 | 58 | 0.160 |
Why?
|
| Adolescent | 4 | 2019 | 9347 | 0.160 |
Why?
|
| Computational Biology | 2 | 2015 | 551 | 0.160 |
Why?
|
| Mutation, Missense | 1 | 2001 | 281 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 177 | 0.160 |
Why?
|
| Phosphoproteins | 1 | 2000 | 261 | 0.160 |
Why?
|
| Maternal Exposure | 1 | 2019 | 58 | 0.160 |
Why?
|
| Adiposity | 1 | 2019 | 76 | 0.160 |
Why?
|
| Middle Aged | 7 | 2019 | 26173 | 0.160 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 2018 | 0.160 |
Why?
|
| Biotin | 2 | 2020 | 45 | 0.160 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 50 | 0.160 |
Why?
|
| Age of Onset | 2 | 2015 | 318 | 0.160 |
Why?
|
| Cell Division | 2 | 2011 | 692 | 0.160 |
Why?
|
| Surface-Active Agents | 2 | 2020 | 61 | 0.160 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1999 | 143 | 0.160 |
Why?
|
| Cystic Fibrosis | 2 | 2018 | 115 | 0.150 |
Why?
|
| Arterioles | 1 | 2018 | 22 | 0.150 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 111 | 0.150 |
Why?
|
| Potassium Channels | 2 | 2005 | 346 | 0.150 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2018 | 46 | 0.150 |
Why?
|
| Phosphatidylcholines | 1 | 2018 | 49 | 0.150 |
Why?
|
| Sodium Compounds | 1 | 2017 | 3 | 0.150 |
Why?
|
| Arsenites | 1 | 2017 | 6 | 0.150 |
Why?
|
| Frozen Sections | 1 | 2018 | 50 | 0.150 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 159 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 82 | 0.150 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2018 | 56 | 0.150 |
Why?
|
| Hemodynamics | 1 | 2021 | 738 | 0.140 |
Why?
|
| Fatty Acids | 1 | 2018 | 134 | 0.140 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 194 | 0.140 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2017 | 11 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2770 | 0.140 |
Why?
|
| Gap Junctions | 1 | 2018 | 144 | 0.140 |
Why?
|
| Sulfonamides | 1 | 2019 | 320 | 0.140 |
Why?
|
| Spleen | 3 | 2006 | 433 | 0.140 |
Why?
|
| Aged | 6 | 2019 | 19272 | 0.130 |
Why?
|
| Autopsy | 1 | 2017 | 124 | 0.130 |
Why?
|
| Models, Animal | 2 | 2010 | 277 | 0.130 |
Why?
|
| Water Pollutants, Chemical | 1 | 2017 | 135 | 0.130 |
Why?
|
| Japan | 4 | 2001 | 304 | 0.130 |
Why?
|
| Drug Resistance | 1 | 2017 | 232 | 0.130 |
Why?
|
| Cytoprotection | 1 | 2016 | 47 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2015 | 521 | 0.130 |
Why?
|
| Energy Metabolism | 1 | 2017 | 282 | 0.130 |
Why?
|
| Sex Factors | 1 | 2019 | 1075 | 0.130 |
Why?
|
| TYK2 Kinase | 1 | 2015 | 7 | 0.120 |
Why?
|
| Child, Preschool | 3 | 2017 | 3773 | 0.120 |
Why?
|
| Pancreatic Function Tests | 1 | 2015 | 7 | 0.120 |
Why?
|
| Cardiovirus Infections | 1 | 2015 | 28 | 0.120 |
Why?
|
| Encephalomyocarditis virus | 1 | 2015 | 40 | 0.120 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2014 | 29 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 78 | 0.120 |
Why?
|
| Rats | 7 | 2011 | 4048 | 0.120 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 2 | 2007 | 30 | 0.120 |
Why?
|
| Pentanoic Acids | 1 | 2014 | 6 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 60 | 0.120 |
Why?
|
| Blood Vessels | 2 | 2005 | 94 | 0.120 |
Why?
|
| Organ Specificity | 4 | 2014 | 277 | 0.120 |
Why?
|
| SOX9 Transcription Factor | 1 | 2014 | 28 | 0.120 |
Why?
|
| Proinsulin | 2 | 2005 | 124 | 0.120 |
Why?
|
| Paired Box Transcription Factors | 1 | 2014 | 52 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 1243 | 0.110 |
Why?
|
| Cell Line | 6 | 2011 | 2495 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 171 | 0.110 |
Why?
|
| Computer Simulation | 3 | 2018 | 1102 | 0.110 |
Why?
|
| Age Factors | 1 | 2019 | 1880 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2016 | 508 | 0.110 |
Why?
|
| Animals, Genetically Modified | 1 | 2014 | 183 | 0.110 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 6787 | 0.110 |
Why?
|
| Biomarkers | 2 | 2017 | 1778 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2011 | 69 | 0.110 |
Why?
|
| Fractals | 1 | 2013 | 42 | 0.110 |
Why?
|
| Morphogenesis | 1 | 2014 | 207 | 0.110 |
Why?
|
| Models, Anatomic | 1 | 2013 | 92 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2019 | 2327 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2015 | 424 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 1396 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 303 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2011 | 36 | 0.090 |
Why?
|
| Calpain | 2 | 2002 | 113 | 0.090 |
Why?
|
| Video Recording | 1 | 2012 | 203 | 0.090 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 85 | 0.090 |
Why?
|
| Dissection | 1 | 2010 | 44 | 0.090 |
Why?
|
| Gene Frequency | 3 | 2001 | 687 | 0.090 |
Why?
|
| Invertebrates | 1 | 2010 | 33 | 0.090 |
Why?
|
| Basement Membrane | 1 | 2010 | 55 | 0.090 |
Why?
|
| Amino Acid Sequence | 4 | 2002 | 2064 | 0.090 |
Why?
|
| Transplantation Tolerance | 1 | 2011 | 138 | 0.090 |
Why?
|
| Proteins | 3 | 2003 | 787 | 0.080 |
Why?
|
| Haplorhini | 1 | 2009 | 81 | 0.080 |
Why?
|
| Cell Size | 1 | 2009 | 69 | 0.080 |
Why?
|
| Developmental Biology | 1 | 2009 | 29 | 0.080 |
Why?
|
| Interferon-gamma | 1 | 2011 | 449 | 0.080 |
Why?
|
| Exons | 3 | 2000 | 453 | 0.080 |
Why?
|
| Vertebrates | 1 | 2010 | 105 | 0.080 |
Why?
|
| Prognosis | 1 | 2017 | 3800 | 0.080 |
Why?
|
| Pancreatic Ducts | 2 | 2005 | 30 | 0.080 |
Why?
|
| Species Specificity | 1 | 2010 | 685 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 450 | 0.080 |
Why?
|
| In Situ Hybridization | 4 | 2005 | 313 | 0.080 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2008 | 7 | 0.080 |
Why?
|
| Child | 3 | 2017 | 7242 | 0.080 |
Why?
|
| Microscopy, Electron | 1 | 2008 | 511 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2007 | 34 | 0.070 |
Why?
|
| Sweetening Agents | 1 | 2007 | 17 | 0.070 |
Why?
|
| Heterochromatin | 1 | 2007 | 24 | 0.070 |
Why?
|
| Alleles | 2 | 2002 | 1137 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2000 | 3024 | 0.070 |
Why?
|
| Birds | 1 | 2009 | 166 | 0.070 |
Why?
|
| Bone Marrow Cells | 2 | 2005 | 262 | 0.070 |
Why?
|
| X Chromosome | 1 | 2007 | 153 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2007 | 153 | 0.070 |
Why?
|
| Uterus | 2 | 1999 | 222 | 0.070 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 26 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 979 | 0.070 |
Why?
|
| Cell Transplantation | 1 | 2006 | 47 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 2395 | 0.060 |
Why?
|
| Bile Ducts | 1 | 2005 | 60 | 0.060 |
Why?
|
| Ischemic Preconditioning | 1 | 2006 | 37 | 0.060 |
Why?
|
| Stochastic Processes | 2 | 2016 | 77 | 0.060 |
Why?
|
| Diabetic Neuropathies | 1 | 2005 | 41 | 0.060 |
Why?
|
| Potassium | 1 | 2006 | 258 | 0.060 |
Why?
|
| Phylogeny | 1 | 2010 | 1198 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2004 | 58 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 563 | 0.060 |
Why?
|
| Reference Values | 2 | 2006 | 662 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 1 | 2003 | 35 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2021 | 2016 | 0.050 |
Why?
|
| Integrases | 1 | 2003 | 63 | 0.050 |
Why?
|
| Cells, Cultured | 4 | 2011 | 2887 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2005 | 1237 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2004 | 919 | 0.050 |
Why?
|
| Introns | 2 | 2000 | 301 | 0.050 |
Why?
|
| Hypothyroidism | 1 | 2004 | 243 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2003 | 302 | 0.050 |
Why?
|
| Dynamin II | 1 | 2021 | 15 | 0.050 |
Why?
|
| Fasting | 1 | 2002 | 162 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 2360 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2021 | 145 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2002 | 793 | 0.050 |
Why?
|
| Heterozygote | 1 | 2002 | 373 | 0.050 |
Why?
|
| Endoderm | 2 | 2011 | 24 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2000 | 85 | 0.040 |
Why?
|
| Endocytosis | 1 | 2021 | 180 | 0.040 |
Why?
|
| Family Health | 1 | 2001 | 162 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2000 | 53 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2017 | 2497 | 0.040 |
Why?
|
| Immobilized Nucleic Acids | 1 | 2020 | 2 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 359 | 0.040 |
Why?
|
| Adipose Tissue | 2 | 2018 | 262 | 0.040 |
Why?
|
| Biotinylation | 1 | 2020 | 42 | 0.040 |
Why?
|
| Aptamers, Nucleotide | 1 | 2020 | 23 | 0.040 |
Why?
|
| Thrombin | 1 | 2020 | 61 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2006 | 1076 | 0.040 |
Why?
|
| Corpus Luteum | 1 | 1999 | 14 | 0.040 |
Why?
|
| Genetic Testing | 2 | 2001 | 543 | 0.040 |
Why?
|
| Cattle | 1 | 2020 | 378 | 0.040 |
Why?
|
| Sulfonylurea Receptors | 1 | 1999 | 50 | 0.040 |
Why?
|
| Receptors, Drug | 1 | 1999 | 54 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2011 | 293 | 0.040 |
Why?
|
| Membrane Potentials | 2 | 2018 | 436 | 0.040 |
Why?
|
| Myometrium | 1 | 1999 | 51 | 0.040 |
Why?
|
| Base Sequence | 2 | 2000 | 2329 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2020 | 245 | 0.040 |
Why?
|
| Genetic Code | 1 | 1998 | 25 | 0.040 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2018 | 4 | 0.040 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2018 | 11 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1998 | 51 | 0.040 |
Why?
|
| Mice, SCID | 2 | 2011 | 259 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2018 | 25 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2018 | 67 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 135 | 0.040 |
Why?
|
| Cytokines | 2 | 2016 | 811 | 0.040 |
Why?
|
| Ovary | 1 | 1999 | 262 | 0.040 |
Why?
|
| Secretory Pathway | 1 | 2017 | 22 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2018 | 152 | 0.040 |
Why?
|
| Placenta | 1 | 1999 | 181 | 0.040 |
Why?
|
| Pregnancy, Animal | 1 | 1997 | 58 | 0.040 |
Why?
|
| Sexual Maturation | 1 | 2017 | 35 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 885 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2019 | 328 | 0.030 |
Why?
|
| Neurons | 1 | 2005 | 1591 | 0.030 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 1996 | 16 | 0.030 |
Why?
|
| Algorithms | 2 | 2015 | 1913 | 0.030 |
Why?
|
| Binding Sites | 1 | 1999 | 1122 | 0.030 |
Why?
|
| Stem Cells | 2 | 2011 | 376 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 1997 | 288 | 0.030 |
Why?
|
| Computer Graphics | 1 | 2016 | 100 | 0.030 |
Why?
|
| Receptors, Purinergic P2 | 1 | 1995 | 16 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 983 | 0.030 |
Why?
|
| Leptin | 3 | 2004 | 102 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 1996 | 228 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 308 | 0.030 |
Why?
|
| Carbocyanines | 1 | 2014 | 18 | 0.030 |
Why?
|
| Succinimides | 1 | 2014 | 12 | 0.030 |
Why?
|
| Streptavidin | 1 | 2014 | 14 | 0.030 |
Why?
|
| Tissue Survival | 1 | 2014 | 13 | 0.030 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2014 | 8 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 14 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 82 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2015 | 186 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1997 | 679 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 294 | 0.030 |
Why?
|
| Cell Communication | 1 | 2014 | 200 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2014 | 153 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2000 | 2887 | 0.030 |
Why?
|
| Tomography, Optical | 1 | 2013 | 9 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 426 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2015 | 602 | 0.030 |
Why?
|
| Chromatin | 1 | 2015 | 404 | 0.020 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2011 | 8 | 0.020 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2011 | 7 | 0.020 |
Why?
|
| SOXF Transcription Factors | 1 | 2011 | 10 | 0.020 |
Why?
|
| Laminin | 1 | 2010 | 89 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 247 | 0.020 |
Why?
|
| Kinetics | 2 | 2006 | 1534 | 0.020 |
Why?
|
| Haplotypes | 2 | 2002 | 637 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 785 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2588 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 557 | 0.020 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2008 | 2 | 0.020 |
Why?
|
| Time Factors | 2 | 2008 | 5361 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2008 | 55 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2008 | 44 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2008 | 23 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2000 | 1074 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 341 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2006 | 64 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2006 | 172 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2008 | 3404 | 0.020 |
Why?
|
| Polyploidy | 1 | 2005 | 18 | 0.020 |
Why?
|
| Embolism | 1 | 2006 | 33 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2005 | 34 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2005 | 39 | 0.020 |
Why?
|
| Androstadienes | 1 | 2006 | 72 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 162 | 0.020 |
Why?
|
| Caspases | 1 | 2006 | 155 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 2005 | 75 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 983 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2006 | 154 | 0.020 |
Why?
|
| Portal Vein | 1 | 2006 | 121 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2008 | 1130 | 0.020 |
Why?
|
| Exocytosis | 1 | 2005 | 109 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1452 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 268 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2005 | 130 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2005 | 403 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2006 | 169 | 0.010 |
Why?
|
| AT Rich Sequence | 1 | 2004 | 7 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 284 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 453 | 0.010 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2005 | 125 | 0.010 |
Why?
|
| Pituitary Diseases | 1 | 2004 | 5 | 0.010 |
Why?
|
| Protein Phosphatase 1 | 1 | 2004 | 34 | 0.010 |
Why?
|
| Calcium Channels | 1 | 2005 | 182 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 194 | 0.010 |
Why?
|
| Nestin | 1 | 2003 | 18 | 0.010 |
Why?
|
| Ischemia | 1 | 2006 | 253 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2003 | 72 | 0.010 |
Why?
|
| Hormones | 1 | 2004 | 139 | 0.010 |
Why?
|
| RNA, Untranslated | 1 | 2003 | 65 | 0.010 |
Why?
|
| Homeostasis | 1 | 2005 | 418 | 0.010 |
Why?
|
| Mesoderm | 1 | 2003 | 124 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2005 | 995 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 140 | 0.010 |
Why?
|
| Arteries | 1 | 2003 | 179 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 241 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 1704 | 0.010 |
Why?
|
| Pedigree | 1 | 2004 | 969 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1929 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2004 | 250 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 435 | 0.010 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2002 | 124 | 0.010 |
Why?
|
| Finland | 1 | 2000 | 28 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2002 | 667 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2000 | 67 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2000 | 476 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 1998 | 25 | 0.010 |
Why?
|
| Receptors, Leptin | 1 | 1997 | 32 | 0.010 |
Why?
|
| Genotype | 1 | 2002 | 1852 | 0.010 |
Why?
|
| Rats, Zucker | 1 | 1996 | 38 | 0.010 |
Why?
|
| Neuropeptide Y | 1 | 1996 | 32 | 0.010 |
Why?
|
| DNA | 1 | 2002 | 1311 | 0.010 |
Why?
|
| Genome, Human | 1 | 2000 | 791 | 0.010 |
Why?
|
| Insulinoma | 1 | 1995 | 37 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 2457 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1995 | 138 | 0.010 |
Why?
|
| Chickens | 1 | 1995 | 212 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 418 | 0.010 |
Why?
|
| Oocytes | 1 | 1995 | 219 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 543 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 645 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 1995 | 397 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1998 | 728 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 1048 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 1008 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1995 | 677 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2004 | 3481 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1995 | 684 | 0.010 |
Why?
|
| United States | 1 | 2000 | 7114 | 0.000 |
Why?
|